SomnoMed Limited (ASX:SOM)
Australia
· Delayed Price · Currency is AUD 0.4500
+0.0100 (2.27%)
Apr 30, 2025, 4:10 PM AEST
SomnoMed Revenue
SomnoMed had revenue of 53.71M AUD in the half year ending December 31, 2024, with 34.40% growth. This brings the company's revenue in the last twelve months to 100.25M, up 12.93% year-over-year. In the fiscal year ending June 30, 2024, SomnoMed had annual revenue of 91.65M with 9.61% growth.
Revenue (ttm)
100.25M
Revenue Growth
+12.93%
P/S Ratio
0.95
Revenue / Employee
334.15K
Employees
300
Market Cap
95.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 91.65M | 8.03M | 9.61% |
| Jun 30, 2023 | 83.62M | 11.04M | 15.20% |
| Jun 30, 2022 | 72.58M | 9.87M | 15.75% |
| Jun 30, 2021 | 62.71M | 5.41M | 9.44% |
| Jun 30, 2020 | 57.30M | -1.60M | -2.71% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |